OTC$LIANY

Lianbio-Adr · Q4 2024 earnings

Q4 2024 earnings · · Investor relations

Headline financials

Total Revenue

$0.00

No prior period
EPS

$3.56

No prior period
Capital Expenditures

-$147K

No prior period
Free Cash Flow

$311M

No prior period
Net Income

$384M

No prior period
Operating Income

-$22.5M

No prior period
Gross Profit

-$347K

No prior period
Cash & Equivalents

$567M

No prior period
Total Assets

$618M

No prior period
R&D Expense

$6.09M

No prior period

Revenue & EPS history

Lianbio-Adr · Revenue · Quarterly

$0

Q4 2024
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+8.4%

Avg return

Earnings day

+8.4%

Avg return

5 days after

-3.1%

Avg return

30 days after

77%

10 / 13 earnings

Positive

+17.7%

Q4 2020

Best reaction

-4.1%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024-2.2%-6.7%-7.4%
Q3 2023+0.7%+1.5%+4.2%
Q2 2023+2.7%+0.0%-9.7%
Q1 2023-4.1%+4.6%+17.7%
Q4 2022-1.2%+17.4%+18.0%
Q3 2022+17.5%+38.9%+7.1%
Q2 2022+11.1%-1.5%-3.0%
Q1 2022+9.3%+29.8%+28.4%
Q4 2021+3.9%+26.1%+7.3%
Q2 2021+17.7%+0.4%-17.3%
Q3 2021+17.7%+0.4%-17.3%
Q4 2020+17.7%+0.4%-17.3%
Q1 2021+17.7%-2.4%-50.4%
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro